Axiostat MIL88

Chitosan-based hemostatic gauze dressing for rapid bleeding control in trauma and surgical settings. Axiostat® activates the coagulation cascade to achieve hemostasis within minutes, suitable for severe wounds and hemorrhage management in military and civilian emergency care.

Chitosan-based hemostatic gauze dressing for rapid bleeding control in emergency and pre-hospital settings. Axiostat activates the body's natural clotting cascade to achieve hemostasis within minutes, reducing blood loss in trauma wounds. Non-adherent formulation minimizes tissue damage during removal.

Axiostat® Vascular Access Haemostasis is a chitosan-based gauze dressing designed for rapid bleeding control in vascular access sites and traumatic wounds. The product combines haemostatic properties with absorbent gauze to achieve rapid hemostasis and reduce blood loss in clinical and emergency settings.

Chitosan-based hemostatic gauze dressing designed for rapid bleeding control in trauma situations. Effective for both civilian and military medical applications requiring immediate hemorrhage management.

Oxicel Powder Hemostat is an absorbable hemostatic agent used to control bleeding during surgical procedures. Applied directly to bleeding surfaces, the powder promotes rapid clot formation and is gradually absorbed by body tissues. Indicated for topical hemostasis in general, cardiac, and vascular surgery.

It is a hemostatic product made by deacetylating chitin extracted from natural materials such as crustaceans to enhance the hemostatic effect and is made from a crustacean-free allergic reaction. It has many advantages such as hemostatic properties, biocompatibility, high absorbency, and antibacterial properties. It increases the cohesiveness of blood fluid by contacting the anions of chitosan and blood, promotes fibrin production, and has a rapid hemostatic mechanism by platelet coagulation. Unlike general hemostatic agents, when removing the gauze after stopping the bleeding, if you pour saline solution or water on the wound, a gelling phenomenon occurs on the gauze surface, preventing secondary bleeding that occurs when removing it. It is divided into a gauze type used for general wounds and a tampon type used for treating female diseases.

Zeolite hemostatic cotton is a sterile absorbent dressing that rapidly controls bleeding through mineral absorption and exothermic reaction. Designed for emergency wound management in clinical and pre-hospital settings, it achieves hemostasis within minutes of application. The product is FDA 510(k) cleared and approved as an innovative medical device in China.

A chitosan-based hemostatic material in gauze format designed for arterial bleeding control in emergency and medical applications. The gauze formulation allows for direct application to bleeding wounds.

Absorbable polysaccharide hemostat for intraoperative bleeding control and wound closure. This regenerative medicine-based hemostatic material provides rapid hemostasis while maintaining biocompatibility and gradual absorption. Indicated for surgical applications requiring reliable bleeding management with minimal tissue trauma.

Celox Chitosan Hemostatic Dressing is a chitosan-based wound care product designed for rapid hemorrhage control in acute trauma and surgical settings. The dressing activates the coagulation cascade to achieve hemostasis within minutes, making it suitable for emergency medicine, military medical applications, and operating room use.

Oxicel is an absorbable hemostatic agent made from oxidized regenerated cellulose, designed to control bleeding during surgical procedures. Applied directly to bleeding surfaces, it promotes clotting through its physical structure and chemical composition. The product is fully absorbable, eliminating the need for removal post-operatively.

Hemostatic wound dressing combining chitosan with proprietary SupraHemo™ formula for rapid bleeding control in emergency, surgical, and tactical settings. Advanced textile integration maximizes contact surface area while minimizing particle shedding and thrombosis risk. Enables patient mobility during hemorrhage management.